Stockreport

Aimmune Therapeutics Announces Closing of Public Offering of Common Stock

AIMMUNE THERAPEUTICS  (AIMT) 
Last aimmune therapeutics earnings: 2/27 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.aimmune.com/corporate-profile
PDF BRISBANE, Calif.--(BUSINESS WIRE)-- Aimmune Therapeutics, Inc. (NASDAQ:AIMT), a biopharmaceutical company developing treatments for potentially life-threat [Read more]